Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1

Interventions

Paclitaxel 292 Gemcitabine 254 Carboplatin 254 Cisplatin 251 Radiotherapy 219 Cyclophosphamide 218 Irinotecan 184 pembrolizumab 181 Docetaxel 174 Bevacizumab 166 Capecitabine 148 Nivolumab 141 Fluorouracil 132 Dexamethasone 125 Bortezomib 123 Oxaliplatin 115 Cytarabine 113 Erlotinib Hydrochloride 112 Temozolomide 110 Sorafenib 110 Doxorubicin 106 Rituximab 105 Leucovorin 105 Etoposide 105 Filgrastim 99 Everolimus 97 Lenalidomide 95 Pemetrexed 90 Ipilimumab 90 fludarabine phosphate 84

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × Lisaftoclax × Clear all

NCT04260217 2025-08-19

MAPLE-1

Ascentage Pharma Group Inc.

Phase 1 Completed

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡